S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
What to watch for as China's major political meeting of the year gets underway
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Trader Joe's chicken soup dumplings recalled for possibly containing permanent marker plastic
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet

Ironwood Pharmaceuticals (IRWD) Earnings Date, Estimates & Call Transcripts

$9.06
-0.37 (-3.92%)
(As of 03/1/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

IRWD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRWD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ironwood Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.18$0.18$0.18 
Q2 20241$0.24$0.24$0.24 
Q3 20241$0.12$0.12$0.12 
Q4 20241$0.08$0.08$0.08 
FY 20244$0.62$0.62$0.62 
Q1 20251$0.25$0.25$0.25 
Q2 20251$0.26$0.26$0.26 
Q3 20251$0.25$0.25$0.25 

IRWD Earnings Date and Information

Ironwood Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Ironwood Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
11/9/2023Q3 2023$0.17$0.12($0.05)$0.15$112.90 million$113.74 million    
8/8/2023Q2 2023$0.25$0.31+$0.06$7.46$103.46 million$107.38 million
5/4/2023Q1 2023$0.24$0.25+$0.01$0.25$100.60 million$104.06 million    
2/16/2023Q4 2022$0.28$0.27($0.01)$0.27$108.23 million$107.20 million    
11/3/2022Q3 2022$0.27$0.28+$0.01$0.28$111.51 million$108.64 million
8/4/2022Q2 2022$0.31$0.21($0.10)$0.21$103.51 million$97.23 million    
5/5/2022Q1 2022$0.27$0.21($0.06)$0.21$96.62 million$97.53 million    
2/17/2022Q4 2021$0.31$0.27($0.04)$0.29$110.18 million$117.13 million    
11/4/2021Q3 2021$0.31$0.33+$0.02$0.32$105.27 million$103.75 million    
8/5/2021Q2 2021$0.23$0.34+$0.11($1.71)$92.47 million$104.00 million  
5/6/2021Q1 2021$0.22$0.24+$0.02$0.23$87.94 million$88.80 million  












Ironwood Pharmaceuticals Earnings - Frequently Asked Questions

When is Ironwood Pharmaceuticals's earnings date?

Ironwood Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on IRWD's earnings history.

How much revenue does Ironwood Pharmaceuticals generate each year?

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded annual revenue of $442.73 million.

How much profit does Ironwood Pharmaceuticals generate each year?

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a recorded net income of -$1.00 billion. IRWD has generated -$6.51 earnings per share over the last four quarters.

What is Ironwood Pharmaceuticals's EPS forecast for next year?

Ironwood Pharmaceuticals's earnings are expected to grow from $0.70 per share to $1.05 per share in the next year, which is a 50.00% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:IRWD) was last updated on 3/3/2024 by MarketBeat.com Staff